Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair

被引:163
作者
Bryant, HE
Helleday, T
机构
[1] Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England
[2] Stockholm Univ, Arrhenius Lab, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden
关键词
D O I
10.1093/nar/gkl108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly (ADP-ribose) polymerase (PARP-1), ATM and DNA-dependent protein kinase (DNA-PK) are all involved in responding to DNA damage to activate pathways responsible for cellular survival. Here, we demonstrate that PARP-1(-/-) cells are sensitive to the ATM inhibitor KU55933 and conversely that AT cells are sensitive to the PARP inhibitor 4-amino-1,8-napthalamide. In addition, PARP-1(-/-) cells are shown to be sensitive to the DNA-PK inhibitor NU7026 and DNA-PKcs or Ku80 defective cells shown to be sensitive to PARP inhibitors. We believe PARP inhibition results in an increase in unresolved spontaneous DNA single-strand breaks (SSBs), which collapse replication forks and trigger homologous recombination repair (HRR). We show that ATM is activated following inhibition of PARP. Furthermore, PARP inhibitor-induced HRR is abolished in ATM, but not DNA-PK, inhibited cells. ATM and DNA-PK inhibition together give the same sensitivity to PARP inhibitors as ATM alone, indicating that ATM functions in the same pathways as DNA-PK for survival at collapsed forks, likely in non-homologous end joining (NHEJ). Altogether, we suggest that ATM is activated by PARP inhibitor-induced collapsed replication forks and may function upstream of HRR in the repair of certain types of double-strand breaks (DSBs).
引用
收藏
页码:1685 / 1691
页数:7
相关论文
共 53 条
  • [1] Cell cycle checkpoint signaling through the ATM and ATR kinases
    Abraham, RT
    [J]. GENES & DEVELOPMENT, 2001, 15 (17) : 2177 - 2196
  • [2] [Anonymous], [No title captured]
  • [3] DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells
    Arnaudeau, C
    Lundin, C
    Helleday, T
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (05) : 1235 - 1245
  • [4] EFFECTS OF PD-128763, A NEW POTENT INHIBITOR OF POLY(ADP-RIBOSE) POLYMERASE, ON X-RAY-INDUCED CELLULAR-RECOVERY PROCESSES IN CHINESE-HAMSTER V79 CELLS
    ARUNDELSUTO, CM
    SCAVONE, SV
    TURNER, WR
    SUTO, MJ
    SEBOLTLEOPOLD, JS
    [J]. RADIATION RESEARCH, 1991, 126 (03) : 367 - 371
  • [5] Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
    Audebert, M
    Salles, B
    Calsou, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) : 55117 - 55126
  • [6] Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL
    Austen, B
    Powell, JE
    Alvi, A
    Edwards, I
    Hooper, L
    Starczynski, J
    Taylor, AMR
    Fegan, C
    Moss, P
    Stankovic, T
    [J]. BLOOD, 2005, 106 (09) : 3175 - 3182
  • [7] Checking on DNA damage in S phase
    Bartek, J
    Lukas, C
    Lukas, J
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (10) : 792 - 804
  • [8] ATM is required for the cellular response to thymidine induced replication fork stress
    Bolderson, E
    Scorah, J
    Helleday, T
    Smythe, C
    Meuth, M
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (23) : 2937 - 2945
  • [9] POTENTIATION OF TEMOZOLOMIDE-INDUCED CYTOTOXICITY - A COMPARATIVE-STUDY OF THE BIOLOGICAL EFFECTS OF POLY(ADP-RIBOSE) POLYMERASE INHIBITORS
    BOULTON, S
    PEMBERTON, LC
    PORTEOUS, JK
    CURTIN, NJ
    GRIFFIN, RJ
    GOLDING, BT
    DURKACZ, BW
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (04) : 849 - 856
  • [10] Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro
    Bowman, KJ
    Newell, DR
    Calvert, AH
    Curtin, NJ
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (01) : 106 - 112